State-of-the-Art Immunology and Immunotherapy in Europe (2nd Edition)

Dear Colleagues,

Immunity represents one of the main pillars of longevity. Disease risk decreases in individuals with a more effective immune system. This begs the question: why do individuals who reach 100 years of age have such powerful immunity? Ultimately, this depends innately on our genetics. Stress, vaccines, drugs, etc., will also positively or negatively influence our immune system and therefore our health. In this Special Issue, we plan to collect studies that describe the behavior of the immune system and explore how to modulate it to determine how our own bodies cure us of diseases and allow us to live a healthier life in old age.

Dr. Juan Gambini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• immunology
• immunotherapy
• lymphocytes
• macrophages
• eosinophils
• neutrophils
• diseases

• State-of-the-Art Immunology and Immunotherapy in Europe in Biomedicines (7 articles)